Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 4Completed 3Not yet recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Prostatic Neoplasms 1Peripheral Nervous System Diseases 1

Interventions

aflutinib 3Saline Solution 3Radiotherapy 3Temozolomide 2Receptors, Interleukin-8B 2Radiosurgery 2Pemetrexed 2Memantine 2Indocyanine Green 2Dexmedetomidine 2Cyclophosphamide 2Carboplatin 2Blood Specimen Collection 2Bevacizumab 2Aminolevulinic Acid 2urinastatin 1trastuzumab deruxtecan 1tovorafenib 1sacituzumab govitecan 1posaconazole 1pembrolizumab 1peginterferon alfa-2b 1osimertinib 1neratinib 1montelukast 1gallium maltolate 1fludarabine 1dalpiciclib 1asciminib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Brain Neoplasms × Memantine × Clear all
NCT07248228 2026-04-08

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
90 enrolled
CNS

Brain Neoplasms

NCT07470606 2026-03-13

MemoryRT

The University of Texas Health Science Center at San Antonio

Phase 2 Not yet recruiting
108 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡